UPDATE: Valeant Pharma (VRX) Exploring Sale of Eye-Surgery Equipment Business - DJ
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
(Updated - November 2, 2016 2:50 PM EDT)
Valeant Pharma (NYSE: VRX) is exploring a sale of its eye-surgery equipment business, according to Dow Jones, citing source.
The unit could fetch $2.5 billion, the report said, though discussions are still preliminary.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OneBeacon Insurance Group (OB) to Explore a Sale - Bloomberg
- Verizon Communications (VZ) May Acquire Big Cable Company - NYP (CHTR) (CMCSA)
- Hartford Financial (HIG) Gains on Unsubstantiated Takeover Catter
Create E-mail Alert Related CategoriesHot M&A, Mergers and Acquisitions, Rumors, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!